Chapter 14, "Analysis and Improvement," builds upon the original framework by introducing more systematic and stringent requirements for the continuous improvement mechanism of the quality management system. The chapter's expansion from the original "Adverse Event Monitoring, Analysis, and Improvement" to "Analysis and Improvement" reflects a profound shift in quality management philosophy from post-event handling to whole-process control.

I. Systematic Improvement of the Quality Management System

Article 119, a newly added general requirement, explicitly states that enterprises shall conduct monitoring, analysis, and improvement activities for both products and the quality management system to ensure product quality, safety, effectiveness, and the continued effective operation of the quality management system. The establishment of this clause creates a systematic management framework for the entire chapter, emphasizing that quality management must focus not only on the product itself but also on the continuous improvement of the system.

Regarding customer feedback handling, Article 120, while retaining the original complaint handling requirements, further clarifies the specific requirements for "timely investigation, evaluation, and handling," and places "customer feedback" alongside "quality complaints." This reflects a management approach that comprehensively values user opinions. This change pushes enterprises to establish more robust customer feedback mechanisms, ensuring that user voices are effectively communicated and addressed.

II. Clarification and Strengthening of Adverse Event Monitoring Responsibilities

Article 121, while continuing the requirement for an adverse event monitoring system, specifically adds the clear stipulation that "the entrusting party shall not transfer adverse event monitoring responsibilities to the entrusted manufacturer through a quality agreement." This important addition definitively clarifies the registrant's primary responsibility in adverse event monitoring, effectively preventing potential responsibility transfer issues under the entrusted production model, and ensuring the effective implementation of adverse event monitoring work.

Simultaneously, the new regulation requires enterprises to promptly conduct investigations, analysis, evaluations, and take measures to control risks for occurred adverse events, emphasizing the "timely release of risk information." These requirements reflect a shift from passive monitoring to proactive risk control, encouraging enterprises to establish more active adverse event response mechanisms.

III. Deepening of Data Analysis and Improvement Mechanisms

Article 122 introduces more specific requirements for data analysis, explicitly stating that enterprises shall "determine appropriate data collection methods, control standards, analysis methods, and statistical techniques." This detailed requirement promotes the establishment of a scientific data analysis system, ensuring the standardization and effectiveness of data analysis work. It is particularly noteworthy that the new regulation requires using data analysis results as input for improvements, emphasizing the management philosophy of data-driven improvement.

Regarding corrective and preventive actions, Article 123 imposes higher requirements on the effectiveness of actions, explicitly stating that "the measures taken shall be commensurate with the impact level of the problem, and verified to have no adverse effects. The effectiveness of the measures shall be confirmed." These specific requirements will effectively enhance the implementation results of corrective and preventive actions, preventing inappropriate measures from causing new quality issues.

IV. Improvement of the Continuous Improvement Mechanism for the Management System

The new regulations introduce more specific requirements for the continuous improvement of the management system. Article 126, within the requirements for the internal audit procedure, adds specific provisions for "developing an internal audit plan and conducting internal audits according to the plan," emphasizing the planned and systematic nature of internal audits. It also requires taking corrective and preventive actions for nonconformities found during the audit and generating an audit report, ensuring closed-loop management of internal audits.

Article 127 sets clearer requirements for management review, stipulating that the review content shall include "product quality evaluation, as well as needs for changes to the quality management system, regulatory compliance, and opportunities for improvement." This requirement drives enterprises to establish a more comprehensive and in-depth management review mechanism, ensuring the quality management system can continuously adapt to changes in the internal and external environment.

V. Strengthening of Risk Control and Information Notification

Regarding risk control, Article 124, while maintaining the requirements for medical device recall management, further clarifies that corresponding risk control measures shall be taken for "medical devices found to have quality defects during the monitoring and analysis process." This wording closely integrates recall management with the enterprise's daily monitoring and analysis work, reflecting a prevention-oriented management philosophy.

Article 125 sets clear requirements for product information notification, emphasizing "timely notification of changes related to product safety to relevant enterprises, user units, or consumers." This requirement helps establish a more transparent product information communication mechanism, ensuring product usage safety.

VI. Implementation Priorities and Compliance Recommendations

Based on the new regulation requirements, enterprises should prioritize the following tasks: First, establish a systematic monitoring and analysis system to ensure comprehensive collection of data related to product quality and quality management system operation. Second, improve the adverse event monitoring mechanism, clarify the responsibilities of all relevant parties, and ensure the effective implementation of monitoring work. Third, optimize data analysis methods and establish scientific data analysis processes to fully leverage the driving role of data in quality improvement. Finally, establish and improve the continuous improvement mechanism, promoting the ongoing optimization of the quality management system through standardized internal audits and management reviews.

During specific implementation, it is recommended that enterprises conduct a comprehensive assessment of their existing quality systems, focusing on the compliance of key areas such as data analysis, adverse event monitoring, and corrective/preventive actions with the new requirements. Simultaneously, strengthen the training of quality management personnel to enhance their data analysis capabilities and system improvement awareness, ensuring the effective execution of the new regulation requirements.

A comparison of the content of Chapter 14 between the old and new versions of the "Medical Device Production Quality Management Guifan" is appended below.